Cargando…
Improvement of Treatment Resistant Depression in a Patient With Primary Hypothyroidism and Thr92Ala5’ Type 2 Deiodinase Gene Polymorphism With Multiple Daily Doses of Triiodothyronine
Introduction: The augmentation pharmacologic therapy used in patients with treatment-resistant depression (TRD) includes drugs such as lithium, buspirone, triiodothyronine (LT3) and other drugs. We report a patient with TRD and primary hypothyroidism who responded to a combination of LT3, given in d...
Autores principales: | Ahmed, Ziyan, Sherin, Rinsha P V, Fonseca, Tatiana De Lourdes, Hoang, Thanh Duc, Shakir, Mohamed K M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265896/ http://dx.doi.org/10.1210/jendso/bvab048.1915 |
Ejemplares similares
-
Desiccated Thyroid Extract Versus Synthetic LT4/T3 Combination Versus LT4 Monotherapy in the Treatment of Primary Hypothyroidism With Special Attention to the Thr92AlaD2 Polymorphism. With Special Attention to the Gene Polymorphism
por: Hoang, Thanh Duc, et al.
Publicado: (2021) -
Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy
por: Ahmed, Ziyan S., et al.
Publicado: (2022) -
Low-Dose Prednisone Therapy is Efficacious in Treating Painful Subacute Thyroiditis
por: Shakir, Mohamed K M, et al.
Publicado: (2021) -
SAT-448 Limited Adaptive Response by Deiodinase Enzymes in the Perinatal Hypothyroid Cochlea
por: Calderon, Maria Uscategui, et al.
Publicado: (2020) -
SAT-511 Alpha Gal Allergy in a Hypothyroid Patient
por: Slayden, Tanner A, et al.
Publicado: (2020)